Global Life Tecnologies, LLC

Global Life Technologies Corp. manufactures Nozin® Nasal Sanitizer®, an antiseptic skin preparation designed to reduce bacterial colonization in hospital and clinical settings. The company specializes in nasal decolonization products and programs aimed at mitigating infection risk in high-acuity environments. Primary clinical applications include ICU decolonization protocols, surgical site infection (SSI) reduction programs, and workplace health and safety initiatives. The Nozin NOVA™ program represents their integrated decolonization solution marketed to healthcare systems. Products are manufactured in the USA. The company positions nasal bacteria as a primary vector in healthcare-associated infection transmission and offers evidence-based protocols targeting this pathway. Nozin is positioned as a consumable component of infection prevention and control (IP) programs and colonization risk mitigation strategies. The company partners with industry organizations including APIC (Association for Professionals in Infection Control and Epidemiology) and Leapfrog Group. Nozin® Nasal Sanitizer® is classified as an antiseptic skin preparation and appears to be available in both professional healthcare and consumer channels.